Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Alzheimer'S Disease : JAD|October 16, 2018
Progress of Brain Amyloid Deposition in Familial Alzheimer's Disease with Taiwan D678H APP MutationYi-Ching Weng, Ing-Tsung Hsiao, Chu-Yun Huang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Association between tumor epidermal growth factor receptor mutation and pulmonary tuberculosis in patients with adenocarcinoma of the lungsYung-Hung Luo, Chieh-Hung Wu, Wen-Shuo Wu, et al.Frontiers in Neurology|June 14, 2019
Tau PET With <sup>18</sup>F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H MutationChin-Chang Huang, Ing-Tsung Hsiao, Chu-Yun Huang, et al.Journal of the Neurological Sciences|February 1, 2019
Amyloid PET pattern with dementia and amyloid angiopathy in Taiwan familial AD with D678H APP mutationChu-Yun Huang, Ing-Tsung Hsiao, Kun-Ju Lin, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 25, 2017
Dual-phase <sup>18</sup>F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer's disease, and healthy controls: A preliminary studyHung-Chou Kuo, Ing-Tsung Hsiao, Chia-Ju Hsieh, et al.Clinical Nuclear Medicine|July 24, 2020
The Imaging Features and Clinical Associations of a Novel Tau PET Tracer-18F-APN1607 in Alzheimer DiseaseJung-Lung Hsu, Kun-Ju Lin, Ing-Tsung Hsiao, et al.Experimental and Therapeutic Medicine|September 13, 2012
Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutationsWen-Shuo Wu, Yuh-Min Chen, Chun-Ming Tsai, et al.Pageof 2